American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 1(54), p. 502-505, 2010
DOI: 10.1128/aac.00858-09
Full text: Download
ABSTRACT This study compared the efficacies of two N -methylglucomine antimoniate (MA) dose regimens for treating macaques with Leishmania braziliensis -induced chronic skin disease. Whereas all animals treated with the full dose (20 mg MA/kg/day) were cured, 50% of the monkeys receiving a low-dose regimen (5 mg MA/kg/day) relapsed. The antimony concentrations in macaque plasma and tissue samples were greater in the full-dose group than in that receiving a subtherapeutic MA regimen. Our data also suggest the presence of drug-induced hepatic pathology.